Value proposition

Creating an ecosystem for innovation in precision medicine.

Precision (aka personalised) medicine is an emerging approach that takes into account individual variation to predict which treatment/prevention strategies will work in which groups of people. For example, colon cancers that have a normally functioning version of a surface protein called KRAS are likely to respond to certain anti-EGFR antibody therapies; those in which the protein is absent or non-fun. Successful innovation in precision medicine requires several sectors (academia, healthcare and industry) work together - often easier said than done.

P4 sits at the intersection of these sectors, leveraging our academic, industry and healthcare connections to create a healthtech ecosystem to supercharge the development and scale of precision medicine technologies.

Our flagship “accelerator” programme is the first of its kind in the UK.

The accelerator provides start-ups with personalised connections and introductions, as well as other support including workshops, personalised coaching (grant writing, AI and IP/regulations), testbeds and trial opportunities and regulatory pathway support to CE marking.

R&D, Health Technology, Investment, Academic Partnerships, Go to Market, International Markets, CE Marking, ISO, Research, Grants, Product Development, NHS, healthtech, startups, start-ups, start-up, digital heath, healthcare, and venture capital